Tammy Furlong - Jul 12, 2023 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Robert Yang, Attorney-in-Fact
Stock symbol
ELEV
Transactions as of
Jul 12, 2023
Transactions value $
$0
Form type
4
Date filed
7/14/2023, 04:29 PM
Next filing
Feb 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Stock Option (Right to Buy) Award $0 +53.4K $0.00 53.4K Jul 12, 2023 Common Stock 53.4K $1.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on July 12, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.